Literature DB >> 1899630

Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families.

V Guigou1, D Emilie, S Berrih-Aknin, F Fumoux, M Fougereau, C Schiff.   

Abstract

Using in situ hybridization, we analysed the immunoglobulin repertoire expressed by the B cells present in myasthenia gravis thymuses from four patients. B cells, mostly in activated state, were clustered in germinal centres, in which multiple isotypes were identified. A majority of cells expressed IgG as compared with IgM, with a roughly similar contribution of kappa and lambda chains. Hybridization with the six VH and the 4 VK human family probes was observed in serial sections, providing additional evidence that individual germinal centres were polyclonal. The thymic B cell repertoire closely reflected the VH and the VK family usage of normal peripheral blood lymphocytes with the preferential utilization of VH3, VK1 and VK3.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899630      PMCID: PMC1535265          DOI: 10.1111/j.1365-2249.1991.tb05625.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.

Authors:  Y Fujii; J Hashimoto; Y Monden; T Ito; K Nakahara; Y Kawashima
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

2.  Organization and evolution of variable region genes of the human immunoglobulin heavy chain.

Authors:  M Kodaira; T Kinashi; I Umemura; F Matsuda; T Noma; Y Ono; T Honjo
Journal:  J Mol Biol       Date:  1986-08-20       Impact factor: 5.469

3.  Subgroup IV of human immunoglobulin K light chains is encoded by a single germline gene.

Authors:  H G Klobeck; G W Bornkamm; G Combriato; R Mocikat; H D Pohlenz; H G Zachau
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

4.  Antibody heterogeneity and specificity in myasthenia gravis.

Authors:  A Vincent; P J Whiting; M Schluep; F Heidenreich; B Lang; A Roberts; N Willcox; J Newsom-Davis
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  B cell precursors are present in the thymus during early development.

Authors:  H Kimoto; T Shirasawa; M Taniguchi; T Takemori
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

6.  Microenvironments in the normal thymus and the thymus in myasthenia gravis.

Authors:  M Bofill; G Janossy; N Willcox; M Chilosi; L K Trejdosiewicz; J Newsom-Davis
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

7.  Human immunoglobulin VH and VK repertoire revealed by in situ hybridization.

Authors:  V Guigou; A M Cuisinier; C Tonnelle; D Moinier; M Fougereau; F Fumoux
Journal:  Mol Immunol       Date:  1990-09       Impact factor: 4.407

8.  Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions.

Authors:  A Fishleder; R Tubbs; B Hesse; H Levine
Journal:  N Engl J Med       Date:  1987-04-30       Impact factor: 91.245

9.  Human immunoglobulin kappa light chain genes of subgroups II and III.

Authors:  H G Klobeck; A Meindl; G Combriato; A Solomon; H G Zachau
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

10.  Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.

Authors:  C L Williams; V A Lennon
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  8 in total

1.  Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis.

Authors:  A E Schröder; J Sieper; C Berek
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

2.  Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia.

Authors:  Rozen Le Panse; Géraldine Cizeron-Clairac; Jacky Bismuth; Sonia Berrih-Aknin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  [Do B cells play an important role in the pathogenesis of rheumatoid arthritis?].

Authors:  C Berek
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

4.  Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis.

Authors:  A E Schröder; A Greiner; C Seyfert; C Berek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

5.  Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.

Authors:  JunMei Zhang; Ge Jia; Qun Liu; Jue Hu; Mei Yan; BaiFeng Yang; Huan Yang; WenBin Zhou; Jing Li
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

6.  Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Authors:  J S Yi; A Guidon; S Sparks; R Osborne; V C Juel; J M Massey; D B Sanders; K J Weinhold; J T Guptill
Journal:  J Autoimmun       Date:  2013-12-28       Impact factor: 7.094

Review 7.  B cells in rheumatoid arthritis.

Authors:  H J Kim; C Berek
Journal:  Arthritis Res       Date:  2000-02-24

Review 8.  CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond.

Authors:  Marcelo G Kazanietz; Michael Durando; Mariana Cooke
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-12       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.